Literature DB >> 19000118

Has the Fistula First Breakthrough Initiative caused an increase in catheter prevalence?

Lawrence M Spergel1.   

Abstract

The use of central venous hemodialysis catheters (CVC) continues to be high among the incident as well as the prevalent HD patients. Whereas many strategies have been implemented to decrease the use of CVCs, their placement rates have doubled since 1996. While many factors, including late referral, are responsible for the increased use of CVCs, the arteriovenous Fistula First Breakthrough Initiative (known as "Fistula First" [FF]) has also been implicated in the increased use of CVCs. It has been suggested that while the FF initiative has resulted in a substantial increase in arteriovenous fistulae placement and use, it has also resulted in an increase in the use of CVCs. This report argues that catheter rates have remained unchanged and provides data regarding the impact of the FF initiative on catheter use.

Entities:  

Mesh:

Year:  2008        PMID: 19000118     DOI: 10.1111/j.1525-139X.2008.00501.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

1.  Hemodialysis vascular access modifies the association between dialysis modality and survival.

Authors:  Jeffrey Perl; Ron Wald; Philip McFarlane; Joanne M Bargman; Edward Vonesh; Yingbo Na; S Vanita Jassal; Louise Moist
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Geographic concentration of poverty and arteriovenous fistula use among ESRD patients.

Authors:  William M McClellan; Haimanot Wasse; Ann C McClellan; James Holt; Jenna Krisher; Lance A Waller
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

3.  Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients.

Authors:  Janet R Lynch; Haimanot Wasse; Nancy C Armistead; William M McClellan
Journal:  Am J Kidney Dis       Date:  2010-11-30       Impact factor: 8.860

4.  Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care.

Authors:  Timmy Lee
Journal:  Cardiovasc Eng Technol       Date:  2017-07-10       Impact factor: 2.495

5.  Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation.

Authors:  Eugene S Lee; Qiang Shen; Robert L Pitts; Mingzhang Guo; Mack H Wu; Sue C Sun; Sarah Y Yuan
Journal:  J Vasc Surg       Date:  2011-05-28       Impact factor: 4.268

6.  Cumulative patency of contemporary fistulas versus grafts (2000-2010).

Authors:  Charmaine E Lok; Jessica M Sontrop; George Tomlinson; Dheeraj Rajan; Mark Cattral; George Oreopoulos; Jeremy Harris; Louise Moist
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

7.  Is the Fistula First Approach still valid?

Authors:  Ricardo Portiolli Franco
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.